Full Press Release Details
Names Thomas T. Higgins Chief Financial Officer
Mass., September 10, 2009 NeuroMetrix, Inc. (Nasdaq: Nuro) today
announced the appointment of Thomas T. Higgins as Senior Vice President and
Chief Financial Officer. The appointment is effective immediately.
brings to NeuroMetrix a broad set of financial management and operations skills
gained in over 30 years of experience with publicly traded companies in life
sciences, specialty chemicals and financial services. He has extensive
international experience with a particular emphasis on Japan, Southeast Asia
and the Middle East.
to joining NeuroMetrix, Mr. Higgins was Executive Vice President and Chief
Financial Officer at Caliper Life Sciences. Inc, a provider of technology and
services for life sciences research, during the period starting in 2005 which
saw strong revenue growth, product line expansion via acquisitions, and
substantial improvement in its financial results. Before Caliper, Mr. Higgins was
Executive Vice President, Operations and Chief Financial Officer at V.I.
Technologies, Inc. ( Vitex ), a biotechnology company addressing blood
safety. Mr. Higgins directed the financial side of the business, including
fund raising, and was also responsible for Vitex FDA-regulated plasma
manufacturing business until its divestiture in 2001. Prior to joining Vitex in
1998, Mr. Higgins served at Cabot Corporation from 1985 in various senior
finance and operations roles. His last position at Cabot was President of
Distrigas of Massachusetts Corporation, a subsidiary involved in the liquefied
natural gas business, and prior to that he was responsible for Cabot s Asia
Pacific carbon black operations. Before joining Cabot, Mr. Higgins was
with PricewaterhouseCoopers where he started his career. Mr. Higgins holds
a BBA with honors from Boston University.
credentials in finance and accounting plus his operations experience are an
excellent fit with our needs, said Shai N. Gozani, M.D., PhD, NeuroMetrix s
President and CEO. We are very pleased to have him on board and look forward
to his contributions as we continue developing NeuroMetrix into a premier
neurotechnology focused healthcare company.
is a science-based health care company transforming patient care through
neurotechnology. We provide innovative products for preservation and
restoration of nerve and spinal cord function, and pain control. To date, our
focus has been primarily on the assessment of neuropathies. Neuropathies affect
the peripheral nerves and parts of the spine and are frequently caused by or
associated with carpal tunnel syndrome, diabetes, sciatica, and other clinical
disorders. We market systems for the performance of nerve conduction studies
and needle electromyography procedures. Our product pipeline includes a system
designed to deliver pharmacologic agents such as anesthetics and
corticosteroids in close proximity to nerves for regional anesthesia, pain
of focal neuropathies. We are also developing devices and pharmaceutical agents
to treat spinal cord injuries. For more information, visit
NeuroMetrix, Inc. Kathleen Cummings, 781-314-2725 Executive Assistant